- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07938788
Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism
This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Anja Bosy-Westphal, Prof. Dr. Dr.
- Telefoonnummer: +49 431 880 5674
- E-mail: abosyw@nutrition.uni-kiel.de
Studie Locaties
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Duitsland, 24105
- Institute of Human Nutrition and Food Science , Department Human Nutrition
-
Contact:
- Anja Bosy-Westphal
- Telefoonnummer: +49 431 880 5674
- E-mail: abosyw@nutrition.uni-kiel.de
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Healthy adults with overweight.
- Age 18-60 years.
- Body mass index (BMI) >=25 and <30 kg/m2.
- Men and women; the study plans an equal distribution of biological sex.
- No regular sports participation; regular sporting activity >=2 h/week is excluded.
- German-speaking, because the study questionnaires are in German and not validated in other languages.
- No anemia or iron deficiency based on screening hemoglobin and ferritin.
- Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- - Individuals unable to provide informed written consent.
- Vegetarian or vegan diet.
- Habitual consumption of more than 5 caffeinated beverages per day.
- Chronic diseases.
- Regular medication use, except oral contraceptives.
- Antibiotic use within 6 weeks before study start.
- Anemia and/or iron deficiency.
- Pregnancy or breastfeeding.
- Cigarette and/or cannabis use, including vaping.
- Food allergies and/or food intolerances.
- Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
- Regular sporting activity >=2 h/week.
- Claustrophobia/fear of confined spaces because of EchoMRI assessment.
- Active participation in another study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Control Diet -> Diverse Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
|
Experimenteel: Diverse Diet -> Control Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Postprandial Insulin
Tijdsspanne: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Postprandial Glucose
Tijdsspanne: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
C-Peptide
Tijdsspanne: 24 hours
|
Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter. |
24 hours
|
|
Non-esterified fatty acids
Tijdsspanne: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Triglycerides
Tijdsspanne: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Tijdsspanne: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Subjective Appetite
Tijdsspanne: 0-300 minutes
|
measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side. |
0-300 minutes
|
|
Energy Expenditure and macronutrient oxidation
Tijdsspanne: 24 hours
|
measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
24 hours
|
|
Gut microbiome composition and Microbiome diversity
Tijdsspanne: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
taxonomy and function via shotgun metagenome sequencing |
Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ABW-2026-GRK
- 54453043/GRK3128 (Ander subsidie-/financieringsnummer: DFG)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .